Get started
Author

Bruna Corominas-Faja

Observed names: BRUNA COROMINAS-FAJA, Bruna Corominas Faja, Bruna Corominas-faja, Corominas-Faja, B, Corominas-Faja, Bruna
OpenAlex ID: A5111716658
The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
2013 · JAVIER MENENDEZ, Jorge Joven, et al. · Cell Cycle · 159
PDF
Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil
2013 · Javier A. Menendez, Jorge Joven, et al. · Cell Cycle · 150
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
2012 · Cristina Oliveras-Ferraros, Bruna Corominas-Faja, et al. · Cell Cycle · 146
PDF
Metformin-induced preferential killing of breast cancer initiating CD44+CD24−/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
2012 · Sílvia Cufí, Bruna Corominas-Faja, et al. · Oncotarget · 143
PDF
Metformin is synthetically lethal with glucose withdrawal in cancer cells
2012 · Javier A. Menendez, Cristina Oliveras-Ferraros, et al. · Cell Cycle · 129
PDF
Cell Cycle Regulation by the Nutrient-Sensing Mammalian Target of Rapamycin (mTOR) Pathway
2014 · Elisabet Cuyàs, Bruna Corominas-Faja, et al. · Methods in molecular biology · 126
Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells
2014 · Bruna Corominas-Faja, Elisabet Cuyàs, et al. · Oncotarget · 119
PDF
Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs
2012 · Bruna Corominas-Faja, Rosa Quirantes-Piné, et al. · Aging · 119
PDF
The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer
2013 · Sílvia Cufí, Alejandro Vazquez-Martin, et al. · Scientific Reports · 116
PDF
Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness
2012 · Alejandro Vazquez-Martin, Sílvia Cufí, et al. · Aging · 116
PDF
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
2013 · BRUNA COROMINAS-FAJA, SÍLVIA CUFÍ, et al. · Cell Cycle · 105
PDF
IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
2013 · Alejandro Vazquez-Martin, Sílvia Cufí, et al. · Scientific Reports · 90
PDF
Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate
2016 · Alejandro Vazquez-Martin, Chris Van den Haute, et al. · Aging · 88
The mitochondrial H+-ATP synthase and the lipogenic switch
2013 · Alejandro Vazquez-Martin, Bruna Corominas-Faja, et al. · Cell Cycle · 86
PDF
Stem cell-like ALDH bright cellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin
2013 · BRUNA COROMINAS-FAJA, Cristina Oliveras-Ferraros, et al. · Cell Cycle · 79
PDF
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
2013 · Sílvia Cufí, Rosa Bonavia, et al. · Scientific Reports · 77
PDF
Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment
2012 · Sílvia Cufí, Alejandro Vazquez-Martin, et al. · Oncotarget · 75
PDF
The nutritional phenome of EMT-induced cancer stem-like cells
2014 · Elisabet Cuyàs, Bruna Corominas-Faja, et al. · Oncotarget · 69
PDF
Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
2017 · Bruna Corominas-Faja, Luciano Vellon, et al. · PubMed · 67
Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells
2013 · Sílvia Cufí, Rosa Bonavia, et al. · Food and Chemical Toxicology · 65
Extra-virgin olive oil contains a metabolo-epigenetic inhibitor of cancer stem cells
2018 · Bruna Corominas-Faja, Elisabet Cuyàs, et al. · Carcinogenesis · 62
PDF
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
2012 · Alejandro Vazquez-Martin, Sílvia Cufi, et al. · Scientific Reports · 60
PDF
Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
2014 · Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, et al. · Cell Cycle · 59
PDF
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
2015 · Elisabet Cuyàs, Salvador Fernández-Arroyo, et al. · Oncotarget · 58
PDF
Basal/HER2 breast carcinomas
2013 · Begoña Martin-Castillo, Cristina Oliveras-Ferraros, et al. · Cell Cycle · 53
PDF
Works count: 49
Citation count: 2,824
H-index: 32
I10-index: 39
Year
Topic
Type